Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8494826rdf:typepubmed:Citationlld:pubmed
pubmed-article:8494826lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0024297lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0202202lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0018134lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0237400lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1706089lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:8494826lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:8494826pubmed:issue4lld:pubmed
pubmed-article:8494826pubmed:dateCreated1993-6-23lld:pubmed
pubmed-article:8494826pubmed:abstractTextThe in vivo activation of lymphokine-producing cells was analyzed in the first 7 days of an acute graft-versus-host reaction (GVHR) induced by injection of C57BL/6 spleen cells into irradiated DBA/2 mice. Although the GVHR was accompanied by a 1000-fold increase in serum IL-6 titers, circulating levels of other lymphokines were low (IL-3, IFN-gamma, and GM-CSF) or undetectable (IL-2 and IL-4). Spleen and lymph node cells from these mice nevertheless produced elevated levels of IL-3, IFN-gamma, GM-CSF, and IL-6 when cultured for 24 h without stimulation; culture with anti-CD3 antibody further increased IL-2, IL-3, IL-4, IFN-gamma, and GM-CSF production by at least 20-fold. Both constitutive and anti-CD3-induced synthesis of all the lymphokines was mediated by CD3+ cells. Messenger RNA analyses revealed the presence of IL-6, IFN-gamma, and GM-CSF transcripts in freshly harvested GVHR spleen cells and increased expression of IL-2, IL-3, IL-4, IFN-gamma, and GM-CSF mRNAs following anti-CD3 stimulation in vitro. In vivo, however, IL-3 mRNA was barely detectable even following cDNA amplification by polymerase chain reaction. In vivo restimulation of day 5 GVHR mice by injection of concanavalin A enhanced expression of IL-3, IL-6, IFN-gamma, and GM-CSF mRNAs and markedly increased serum titers of the corresponding lymphokines, which peaked 6-12 h after injection at levels at least 10- to 100-fold higher than in concanavalin A-treated normal mice.2+ for high-level synthesis of all these lymphokines.lld:pubmed
pubmed-article:8494826pubmed:languageenglld:pubmed
pubmed-article:8494826pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494826pubmed:citationSubsetIMlld:pubmed
pubmed-article:8494826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8494826pubmed:statusMEDLINElld:pubmed
pubmed-article:8494826pubmed:monthAprlld:pubmed
pubmed-article:8494826pubmed:issn0953-8178lld:pubmed
pubmed-article:8494826pubmed:authorpubmed-author:KelsoAAlld:pubmed
pubmed-article:8494826pubmed:authorpubmed-author:TrouttA BABlld:pubmed
pubmed-article:8494826pubmed:issnTypePrintlld:pubmed
pubmed-article:8494826pubmed:volume5lld:pubmed
pubmed-article:8494826pubmed:ownerNLMlld:pubmed
pubmed-article:8494826pubmed:authorsCompleteYlld:pubmed
pubmed-article:8494826pubmed:pagination399-407lld:pubmed
pubmed-article:8494826pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:meshHeadingpubmed-meshheading:8494826-...lld:pubmed
pubmed-article:8494826pubmed:year1993lld:pubmed
pubmed-article:8494826pubmed:articleTitleLymphokine synthesis in vivo in an acute murine graft-versus-host reaction: mRNA and protein measurements in vivo and in vitro reveal marked differences between actual and potential lymphokine production levels.lld:pubmed
pubmed-article:8494826pubmed:affiliationWalter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.lld:pubmed
pubmed-article:8494826pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8494826pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8494826pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8494826pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8494826lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8494826lld:pubmed